Add
ACRX to Portfolio
Set Alert
Email to a
Friend
| |||
|
|
Quotes & Info
|
| ACRX > SEC Filings for ACRX > Form 8-K on 13-Aug-2012 | All Recent SEC Filings |
13-Aug-2012
Results of Operations and Financial Condition, Financial Statements an
On August 9, 2012, AcelRx Pharmaceuticals, Inc. (the "Company") issued a press release announcing its financial results for the quarter ended June 30, 2012. A copy of the press release is furnished as Exhibit 99.1 to this report.
The information in this Item 2.02 and in the press release furnished as Exhibit
99.1 to this current report shall not be deemed to be "filed" for purposes of
Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise
subject to the liabilities of that Section or Sections 11 and 12(a)(2) of the
Securities Act of 1933, as amended. The information contained in this Item 2.02
and in the press release furnished as Exhibit 99.1 to this current report shall
not be incorporated by reference into any filing with the U.S. Securities and
Exchange Commission made by the Company, whether made before or after the date
hereof, regardless of any general incorporation language in such filing.
(d) Exhibits.
99.1 Press Release dated August 9, 2012.
|
|